188 related articles for article (PubMed ID: 8772781)
1. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up.
Epstein JI; Partin AW; Sauvageot J; Walsh PC
Am J Surg Pathol; 1996 Mar; 20(3):286-92. PubMed ID: 8772781
[TBL] [Abstract][Full Text] [Related]
2. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.
Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC
Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy.
Chan TY; Partin AW; Walsh PC; Epstein JI
Urology; 2000 Nov; 56(5):823-7. PubMed ID: 11068310
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.
Pound CR; Partin AW; Epstein JI; Walsh PC
Urol Clin North Am; 1997 May; 24(2):395-406. PubMed ID: 9126237
[TBL] [Abstract][Full Text] [Related]
5. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer.
Valicenti RK; Chervoneva I; Gomella LG
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1093-7. PubMed ID: 15001249
[TBL] [Abstract][Full Text] [Related]
6. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
Epstein JI; Carmichael M; Partin AW; Walsh PC
J Urol; 1993 Jun; 149(6):1478-81. PubMed ID: 8501792
[TBL] [Abstract][Full Text] [Related]
7. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy.
Freedland SJ; Aronson WJ; Presti JC; Amling CL; Terris MK; Trock B; Kane CJ
Cancer; 2004 Apr; 100(8):1633-8. PubMed ID: 15073850
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
[TBL] [Abstract][Full Text] [Related]
9. [Seminal vesicle invasion afer radical prostatectomy: study of risk factors for progression].
Salomon L; Levrel O; de la Taille A; Hoznek A; Chopin D; Abbou CC
Prog Urol; 2002 Sep; 12(4):621-7. PubMed ID: 12463121
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score < or = 7.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Tomaszewski JE; Wein A
Cancer; 2000 May; 88(9):2110-5. PubMed ID: 10813723
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.
Palapattu GS; Allaf ME; Trock BJ; Epstein JI; Walsh PC
J Urol; 2004 Nov; 172(5 Pt 1):1860-4. PubMed ID: 15540739
[TBL] [Abstract][Full Text] [Related]
12. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup.
Epstein JI; Carmichael MJ; Pizov G; Walsh PC
J Urol; 1993 Jul; 150(1):135-41. PubMed ID: 7685422
[TBL] [Abstract][Full Text] [Related]
13. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
[TBL] [Abstract][Full Text] [Related]
14. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles.
Johnson CW; Anastasiadis AG; McKiernan JM; Salomon L; Eaton S; Goluboff ET; Olsson CA; Benson MC
Urol Oncol; 2004; 22(2):107-11. PubMed ID: 15082006
[TBL] [Abstract][Full Text] [Related]
15. Correlation of pathologic findings with progression after radical retropubic prostatectomy.
Epstein JI; Pizov G; Walsh PC
Cancer; 1993 Jun; 71(11):3582-93. PubMed ID: 7683970
[TBL] [Abstract][Full Text] [Related]
16. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.
Walsh PC; Partin AW; Epstein JI
J Urol; 1994 Nov; 152(5 Pt 2):1831-6. PubMed ID: 7523730
[TBL] [Abstract][Full Text] [Related]
17. Nondissection of pelvic lymph nodes does not influence the results of perineal radical prostatectomy in selected patients.
Salomon L; Hoznek A; Lefrère-Belda MA; Bellot J; Chopin DK; Abbou CC
Eur Urol; 2000 Mar; 37(3):297-300. PubMed ID: 10720855
[TBL] [Abstract][Full Text] [Related]
18. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status.
Masterson TA; Pettus JA; Middleton RG; Stephenson RA
Urology; 2005 Jul; 66(1):152-5. PubMed ID: 15992904
[TBL] [Abstract][Full Text] [Related]
19. Disease progression following radical prostatectomy in men with Gleason score 7 tumor.
Epstein JI; Pound CR; Partin AW; Walsh PC
J Urol; 1998 Jul; 160(1):97-100; discussion 101. PubMed ID: 9628613
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
Epstein JI; Walsh PC; Brendler CB
J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
